Home » Stocks » VEEV

Veeva Systems Inc. (VEEV)

Stock Price: $276.45 USD 0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed
Pre-market: $276.85 +0.40 (0.15%) Nov 30, 7:33 AM

Stock Price Chart

Key Info

Market Cap 37.52B
Revenue (ttm) 1.28B
Net Income (ttm) 328.55M
Shares Out 135.73M
EPS (ttm) 2.06
PE Ratio 134.20
Forward PE 86.96
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $276.45
Previous Close $276.45
Change ($) 0.00
Change (%) 0.00%
Day's Open 268.69
Day's Range 265.41 - 276.87
Day's Volume 750,483
52-Week Range 120.93 - 308.55

More Stats

Market Cap 37.52B
Enterprise Value 36.08B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 135.73M
Float n/a
EPS (basic) 2.21
EPS (diluted) 2.06
FCF / Share 3.20
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.75%
FCF Yield 1.28%
Payout Ratio n/a
Shares Short 1.91M
Short Ratio 2.26
Short % of Float n/a
Beta 0.95
PE Ratio 134.20
Forward PE 86.96
P/FCF Ratio 77.90
PS Ratio 29.24
PB Ratio 21.31
Revenue 1.28B
Operating Income 318.84M
Net Income 328.55M
Free Cash Flow 481.64M
Net Cash 1.44B
Net Cash / Share 10.60
Gross Margin 62.40%
Operating Margin 24.85%
Profit Margin 25.60%
FCF Margin 37.53%
ROA 9.14%
ROE 19.32%
ROIC 50.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (23)

Buy 13
Overweight 2
Hold 7
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$303.76*
(9.88% upside)
Low
225
Current: $276.45
High
335
Target: 303.76
*Average 12-month price target from 21 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1,10486269155140931321013061.2629.13
Revenue Growth28.05%24.86%25.43%34.53%30.65%49.05%62.22%111.47%110.31%-
Gross Profit80161747937726719812872.5332.2116.81
Operating Income28622315812178.5969.9739.3030.036.645.09
Net Income30123015177.5754.4140.1410.413.480.600.43
Shares Outstanding14814414013613212851.7320.8917.6613.16
Earnings Per Share1.901.470.980.530.380.280.150.110.020.02
EPS Growth29.25%50%84.91%39.47%35.71%86.67%36.36%450%0%-
Operating Cash Flow43731123314480.1567.5741.7530.804.744.90
Capital Expenditures-4.32-9.82-11.37-7.51-21.58-26.94-2.98-1.55-1.19-0.58
Free Cash Flow43330122213758.5740.6338.7829.253.544.32
Cash & Equivalents1,0871,09076251934639828846.4217.13-
Total Debt54.83---------
Net Cash / Debt1,0321,09076251934639828846.4217.13-
Assets2,2721,6541,23091770654537089.8241.41-
Liabilities60641632426520113890.2155.8527.31-
Book Value1,6661,23890665350540728033.9714.10-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Veeva Systems Inc.
Country United States
Employees 3,501
CEO Peter P. Gassner

Stock Information

Ticker Symbol VEEV
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Health Information Services
Unique Identifier NYSE: VEEV
IPO Date October 16, 2013

Description

Veeva Systems provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. Veeva Systems has collaboration with RedHill Biopharma Ltd. to enhance value of Opaganib Phase 2/3 COVID-19 clinical data. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.